Literature DB >> 16827253

Hyperhomocysteinemia and coronary artery disease in Pakistan.

M Perwaiz Iqbal1.   

Abstract

The relative risk of developing coronary artery disease (CAD) in Pakistani men is highest in early ages. Majority of those suffering from CAD belong to the lower middle socioeconomic stratum of the society. Mild hyperhomocysteinemia (concentration of plasma homocysteine between 15-25 micromol/l) is very commonly seen in Pakistani patients with acute myocardial infarction (AMI) as well as in normal healthy subjects. There appears to be a lack of association between hyperhomocysteinemia and CAD in Pakistani population. There is also no evidence of association of methylenetetrahydrofolate reductase 677C>T mutation with CAD in this population. High prevalence of deficiency of folate and vitamin B6 appears to be the major causes of hyperhomocysteinemia in Pakistani population. Deficiencies of micronutrients (folate, vitamin B6 and possibly vitamin B12) along with mild hyperhomocysteinemia, perhaps, act synergistically with other classical risk factors in Pakistani population to further increase the risk of CAD.

Entities:  

Mesh:

Year:  2006        PMID: 16827253

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Association of blood lead (Pb) and plasma homocysteine: a cross sectional survey in Karachi, Pakistan.

Authors:  Mohsin Yakub; Mohammad Perwaiz Iqbal
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

2.  Correlation of hyper-homocysteinemia with coronary artery disease in absence of conventional risk factors among young adults.

Authors:  Hammad Shah; Muneeb Ullah Jan; Afrasyab Altaf; Momin Salahudin
Journal:  J Saudi Heart Assoc       Date:  2018-05-09

3.  Coronary calcium scoring: are the results comparable to computed tomography coronary angiography for screening coronary artery disease in a South Asian population?

Authors:  Nizar Bhulani; Ali Khawaja; Asif Jafferani; Maryam Baqir; Ramin Ebrahimi; Zafar Sajjad
Journal:  BMC Res Notes       Date:  2013-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.